U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
144031144031Statin Therapy in the Treatment of SepsisCompletedNo Results AvailableSeptic ShockDrug: Simvastatin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00676897
144032144032A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic EczemaCompletedNo Results AvailableAtopic EczemaDrug: Aeroderm (also known as pitrakinra, AER 001, BAY 16-9996)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00676884
144033144033A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)WithdrawnNo Results AvailableChronic Lymphocytic LeukemiaDrug: MEDI-538|Drug: MEDI-538|Drug: MEDI-538|Drug: MEDI-538|Drug: MEDI-538|Drug: MEDI-538|Drug: MEDI-538https://ClinicalTrials.gov/show/NCT00676871
144034144034Gas Embolism With Use of Argon Plasma CoagulationRecruitingNo Results AvailableEmbolism, Airhttps://ClinicalTrials.gov/show/NCT00676858
144035144035Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial ProtectionCompletedNo Results AvailableMetabolic Syndrome|HypertensionDrug: olmesartan medoxomil|Drug: placebo|Drug: olmesartan medoxomil|Drug: olmesartan medoxomilhttps://ClinicalTrials.gov/show/NCT00676845
144036144036Study of COLAL-PRED to Treat Moderate to Severe Ulcerative ColitisCompletedNo Results AvailableColitis, UlcerativeDrug: Placebo|Drug: COLAL-PREDhttps://ClinicalTrials.gov/show/NCT00676832
144037144037Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin aspart|Drug: human insulinhttps://ClinicalTrials.gov/show/NCT00676819
144038144038A Phase II Study of Umbilical Cord Blood TransplantationCompletedNo Results AvailableLeukemia|Lymphoma|Multiple Myeloma|Aplastic AnemiaBiological: Umbilical Cord Blood Transplantation After Myeloablative Conditioning|Biological: Umbilical Cord Blood Transplantation After Reduced-Intensity Conditioninghttps://ClinicalTrials.gov/show/NCT00676806
144039144039A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer ProgressionActive, not recruitingHas ResultsBreast CancerDrug: Polyphenon Ehttps://ClinicalTrials.gov/show/NCT00676793
144040144040Green Tea Extract and Prostate CancerCompletedHas ResultsProstate CancerDrug: Polyphenon E (EGCG)https://ClinicalTrials.gov/show/NCT00676780
144041144041Resistant Starch on Glycemic Response in Older AdultsCompletedNo Results AvailableHyperglycemiaDietary Supplement: Resistant Starch Type 4|Dietary Supplement: Dextrose|Dietary Supplement: Puffed wheathttps://ClinicalTrials.gov/show/NCT00676767
144042144042Epidemiology of MDR-TB in PeruActive, not recruitingNo Results AvailableTB Multi-drug ResistantProcedure: Statens Serum Institut RT23 2TU tuberculinhttps://ClinicalTrials.gov/show/NCT00676754
144043144043Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin aspart|Drug: biphasic insulin aspart 30|Drug: insulin detemirhttps://ClinicalTrials.gov/show/NCT00676741
144044144044A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic SyndromeTerminatedNo Results AvailableAdvanced or Refractory Leukemia|Myelodysplastic SyndromesDrug: JNJ-26481585https://ClinicalTrials.gov/show/NCT00676728
144045144045A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple SclerosisActive, not recruitingNo Results AvailableMultiple Sclerosis, Relapsing-RemittingDrug: interferon beta-1a|Drug: methylprednisolone|Drug: ocrelizumab|Drug: placebohttps://ClinicalTrials.gov/show/NCT00676715
144046144046A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)CompletedNo Results AvailableExocrine Pancreatic Insufficiency|Pancreatitis, Chronic|Steatorrhea|PancreatitisDietary Supplement: Ensure Plus|Drug: Pancrelipase in combination with Ensure Plushttps://ClinicalTrials.gov/show/NCT00676702
144047144047COMPASSION: COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THVActive, not recruitingNo Results AvailablePulmonary Valve Insufficiency|Pulmonary Regurgitation|Dysfunctional RVOT Conduit|Pulmonary Obstruction|Pulmonary StenosisDevice: SAPIEN Transcatheter Valve Implantationhttps://ClinicalTrials.gov/show/NCT00676689
144048144048Effects of Testosterone in Women With DepressionCompletedHas ResultsDepressionDrug: Testosteronehttps://ClinicalTrials.gov/show/NCT00676676
144049144049Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast CancerCompletedNo Results AvailableBreast Cancer|Estrogen Receptor-Positive Breast Cancer|Breast Cancer, Estrogen Receptor-Positive|ER+ Breast CancerDrug: entinostat|Drug: exemestanehttps://ClinicalTrials.gov/show/NCT00676663
144050144050Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyTerminatedHas ResultsProstatic NeoplasmsDrug: Prednisone|Drug: sunitinib|Drug: Placebo|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00676650
144051144051Glaucoma Adherence StudyCompletedNo Results AvailableOcular Hypertension|Primary Open Angle GlaucomaDrug: Travoprost 0.004%/timolol 0.05% fixed combination eye drops (DuoTrav)|Device: Travalert Dosing Aidhttps://ClinicalTrials.gov/show/NCT00676637
144052144052Infectious Causes of UveitisCompletedNo Results AvailableUveitishttps://ClinicalTrials.gov/show/NCT00676624
144053144053Acetabular Fractures of Both ColumnsEnrolling by invitationNo Results AvailableAcetabular Fractures|Both Columnshttps://ClinicalTrials.gov/show/NCT00676611
144054144054A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac ArrestCompletedNo Results AvailableCardiac Arresthttps://ClinicalTrials.gov/show/NCT00676598
144055144055Corticosteroid Therapy in Refractory Shock Following Cardiac ArrestCompletedNo Results AvailableCardiac ArrestDrug: Normal Saline|Drug: Hydrocortisonehttps://ClinicalTrials.gov/show/NCT00676585
144056144056p38 Mitogen−Activated Protein Kinase (MAPK) and Steroid Insensitivity in AsthmaActive, not recruitingNo Results AvailableAsthmaOther: Fiberoptic bronchoscopy; blood testhttps://ClinicalTrials.gov/show/NCT00676572
144057144057Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME StudyWithdrawnNo Results AvailableDiabetic Macular EdemaDrug: Efalizumab|Drug: Ranibizumabhttps://ClinicalTrials.gov/show/NCT00676559
144058144058[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT00676546
144059144059Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract InfectionsCompletedNo Results AvailableUrinary Tract InfectionDrug: Cipro XR (Ciprofloxacin, BAYQ3939)https://ClinicalTrials.gov/show/NCT00676533
144060144060XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)CompletedHas ResultsCoronary Artery DiseaseDevice: XIENCE V® Everolimus Eluting Coronary Stenthttps://ClinicalTrials.gov/show/NCT00676520

* Görseller ve İçerik tekif hakkına sahip olabilir